News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Gosebruch Henry O
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 05/11/2023 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on ACELYRIN, Inc.|
Txns:
| Bought 50,000 shares
@ $18, valued at
$900k
Disposed of 155,450 options to buy
@ $7.4345, valued at
$1.2M
Acquired 155,450 options to buy
@ $7.4345, valued at
$1.2M
|
|
| 05/31/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/18/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/01/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/22/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2020 |
4
| Gosebruch Henry O (EVP, Chief Strategy Officer) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 6,900 shares
@ $98.83, valued at
$681.9k
Sold 33,100 shares
@ $99.49, valued at
$3.3M
|
|
| 10/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 40,000 options to buy
@ $3.84, valued at
$153.6k
|
|
| 04/24/2020 |
4
| Gosebruch Henry O (EVP, Chief Strategy Officer) has filed a Form 4 on AbbVie Inc.|
Txns:
| Gifted 18,500 shares
@ $0
Gifted 18,500 shares
@ $0 |
|
| 04/02/2020 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 7,374 options to buy
@ $2.16, valued at
$15.9k
|
|
| 03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/14/2020 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Bought 25,000 shares
@ $3, valued at
$75k
|
|
| 01/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/16/2019 |
4
| Gosebruch Henry O (EVP, Chief Strategy Officer) has filed a Form 4 on AbbVie Inc.|
Txns:
| Gifted 30,000 shares
@ $0
Gifted 30,000 shares
@ $0 |
|
| 07/31/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/02/2019 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 2,649 options to buy
@ $3.34, valued at
$8.8k
|
|
| 05/17/2019 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Granted 80,000 options to buy
@ $3.73, valued at
$298.4k
|
|
| 05/09/2019 |
4
| Gosebruch Henry O (Director) has filed a Form 4 on Aptinyx Inc.|
Txns:
| Bought 3,420 shares
@ $3.75, valued at
$12.8k
Bought 96,580 shares
@ $3.86, valued at
$372.8k
|
|
| 03/04/2019 |
4
| Gosebruch Henry O (EVP, Chief Strategy Officer) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 22,956 shares
@ $79.41, valued at
$1.8M
|
|
| 02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/11/2018 |
4
| Gosebruch Henry O (EVP, Chief Strategy Officer) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 13,446 shares
@ $86.96, valued at
$1.2M
|
|
| 11/30/2018 |
4
| Gosebruch Henry O (EVP, Chief Strategy Officer) has filed a Form 4 on AbbVie Inc.|
Txns:
| Sold 42,450 shares
@ $90.1046, valued at
$3.8M
|
|
| 03/02/2018 |
4
| Gosebruch Henry O (EVP, Chief Strategy Officer) has filed a Form 4 on AbbVie Inc.|
Txns:
| Paid exercise price by delivering 17,418 shares
@ $118.26, valued at
$2.1M
|
|
| 02/16/2018 |
4
| Gosebruch Henry O (EVP, Chief Strategy Officer) has filed a Form 4 on AbbVie Inc.|
Txns:
| Granted 14,034 shares
@ $0
Granted 13,552 shares
@ $0
Granted 11,730 shares
@ $0
Granted 35,440 options to buy
@ $114.36, valued at
$4.1M
|
|
|
|
|